Literature DB >> 10962567

Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.

S Y Leung1, S T Yuen, T L Chan, A S Chan, J W Ho, K Kwan, Y W Fan, K N Hung, L P Chung, A H Wyllie.   

Abstract

We have previously reported high-frequency microsatellite instability (MSI-H) and germ-line mismatch repair gene mutation in patients with unusually young onset of high-grade glioma. Some of these patients developed metachronous MSI-H colorectal cancer and conformed to the diagnosis of Turcot's syndrome. Frameshift mutation of TGFbetaRII was present in all the colorectal carcinomas but not in brain tumours. We further characterized the genetic pathways of tumour evolution in these metachronous gliomas and colorectal carcinomas. All MSI-H glioblastomas had inactivation of both alleles of the p53 gene and showed over-expression of the p53 protein while none of the colorectal carcinomas had p53 mutation or protein over-expression. Flow cytometry and comparative genomic hybridization revealed that all glioblastomas were chromosomal unstable with aneuploid DNA content, and with a variable number of chromosomal arm aberrations. In contrast, the colorectal carcinomas had diploid or near-diploid DNA content with few chromosomal arm aberrations. The pattern of chromosomal aberrations in the two organs was different. Loss of 9p was consistently observed in all glioblastomas but not in colorectal carcinomas. Epidermal growth factor receptor amplification was absent in all glioblastomas and colorectal carcinomas. Our results suggest that both the frequency of p53 mutation and its effects differ greatly in the two organs. Following loss of mismatch repair function, p53 inactivation and chromosomal instability are not necessary for development of colorectal carcinoma, but are required for genesis of glioblastoma. Oncogene (2000) 19, 4079 - 4083.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962567     DOI: 10.1038/sj.onc.1203740

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.

Authors:  B Beheshti; P C Park; J M Sweet; J Trachtenberg; M A Jewett; J A Squire
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

3.  Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma.

Authors:  Yingying Lin; Keman Liao; Yifeng Miao; Zhongrun Qian; Zhaoyuan Fang; Xi Yang; Quanmin Nie; Gan Jiang; Jianhua Liu; Yiyi Yu; Jieqing Wan; Xiaohua Zhang; Yaomin Hu; Jiyao Jiang; Yongming Qiu
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

Review 4.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation.

Authors:  Alexander F Jeans; Ian Frayling; Bharat Jasani; Lucy Side; Claire Blesing; Olaf Ansorge
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

6.  dp53 Restrains ectopic neural stem cell formation in the Drosophila brain in a non-apoptotic mechanism involving Archipelago and cyclin E.

Authors:  Yingshi Ouyang; Yan Song; Bingwei Lu
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

7.  Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients.

Authors:  Chieu B Diep; Manuel R Teixeira; Lin Thorstensen; Johan N Wiig; Mette Eknaes; Jahn M Nesland; Karl-Erik Giercksky; Bertil Johansson; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2004-02-23       Impact factor: 27.401

8.  Lack of EGF receptor contributes to drug sensitivity of human germline cells.

Authors:  S-J Park; S Armstrong; C-H Kim; M Yu; K Robertson; M R Kelley; S-H Lee
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

Review 9.  The Process and Regulatory Components of Inflammation in Brain Oncogenesis.

Authors:  A G M Mostofa; Surendra R Punganuru; Hanumantha Rao Madala; Mohammad Al-Obaide; Kalkunte S Srivenugopal
Journal:  Biomolecules       Date:  2017-03-27

10.  Aberrant signaling pathways in glioma.

Authors:  Mitsutoshi Nakada; Daisuke Kita; Takuya Watanabe; Yutaka Hayashi; Lei Teng; Ilya V Pyko; Jun-Ichiro Hamada
Journal:  Cancers (Basel)       Date:  2011-08-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.